spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Organon 

 HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Sep 2022
Mallinckrodt Announces Appointment of Lisa French as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Mar 2022
Neuraxpharm appoints Tom Coogan as new Country Manager for Ireland
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2021
Veteran Biopharma Executive Dane D. Hallberg Launches MASORI Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2017
OrthoGrid Systems, Inc. Announces Mark J. Carrico as Director of Marketing
Devices Orthopaedic Personnel
 HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2016
Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 21 May 2014
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2014
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
Biopharmaceuticals Urology Gastroenterology Personnel
 HSMN NewsFeed - 9 Jan 2014
OvaScience Appoints David Stern to Executive Vice President, Global Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2013
TherapeuticsMD Appoints Joel S. Krasnow, M.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2013
AMAG Pharmaceuticals Appoints Robert F. Kaper, M.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Sep 2013
Forest Laboratories Names Brent Saunders CEO and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Aug 2013
ACADIA Pharmaceuticals Announces Appointment of Terrence Moore as Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Sep 2011
NPS Pharmaceuticals Appoints Eric Pauwels as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2011
LipoScience Appoints Thomas Clement Vice President of Regulatory and Quality Affairs
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 4 Nov 2010
OctoPlus Appoints Jan Hendrik Egberts as CEO
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 15 Mar 2010
Bausch & Lomb Names Fred Hassan as Chairman, Brent Saunders as Chief Executive Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 12 Nov 2009
Mirna Therapeutics Appoints Dr. Paul Lammers as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2009
Lilly Names New Business Leaders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Biopharmaceuticals
 HSMN NewsFeed - 24 Jul 2009
SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2009
Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Feb 2009
Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2009
U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 10 Sep 2008
Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
Biopharmaceuticals
 HSMN NewsFeed - 19 Aug 2008
Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 30 Jun 2008
Tobira Therapeutics Inc. Announces Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2008
Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2008
Cortex Pharmaceuticals Announces Management Changes
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 6 May 2008
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
Accentia Announces that After Reviewing Unblinded Results, Independent DMC Recommends Presenting Data on BiovaxID(R) to FDA and Worldwide Regulatory Agencies in Order to Seek Marketing Approvals for Follicular Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Apr 2008
Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being
Biopharmaceuticals
 HSMN NewsFeed - 10 Apr 2008
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2008
EKR Therapeutics Announces Management Additions and Promotions, Reflecting Support of Continued Acceleration in Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2008
Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Mar 2008
Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Mar 2008
FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2008
Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Mar 2008
Cortex Receives Approval from German Regulatory Authority to Proceed with Two Clinical Trials for AMPAKINE(R) CX717 for the Acute Treatment of Respiratory Depression Due to Opiate Analgesics
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Feb 2008
Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
Diagnostics
 HSMN NewsFeed - 11 Feb 2008
Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
Diagnostics
 HSMN NewsFeed - 8 Feb 2008
Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2008
Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 4 Feb 2008
FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Feb 2008
Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2008
FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jan 2008
Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Dec 2007
Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
Biopharmaceuticals Distribution
 HSMN NewsFeed - 16 Nov 2007
Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Nov 2007
Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 12 Nov 2007
Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2007
Gene Logic Selects New Company Name: Ore Pharmaceuticals Inc.
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2007
Cortex Names Pierre V. Tran, MD, MMM, Chief Medical Officer and Vice President of Clinical Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Oct 2007
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Oct 2007
Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Sep 2007
Lexicon Appoints Judith Swain, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2007
Cortex Files AMPAKINE CX717 IND for ADHD
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Sep 2007
Pharmacopeia Announces Senior Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Aug 2007
KineMed and Merck Enter Collaboration in Atherosclerosis
Biopharmaceuticals
 HSMN NewsFeed - 1 Aug 2007
Eslax(R) (Rocuronium Bromide) Approved in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 31 Jul 2007
Gene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2007
Cortex to Resume Clinical Trial with AMPAKINE(R) CX717 in Alzheimer-PET Scan Study after FDA Approves Protocol with Higher Doses of Drug
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Jun 2007
Organon's Once-a-Month Contraceptive Ring, NuvaRing(R) Completes European Authorization
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Jun 2007
Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
Biopharmaceuticals
 HSMN NewsFeed - 17 May 2007
Cortex's AMPAKINE(R) Drug May Offer New Hope for Memory Problems Associated with Huntington's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 May 2007
Medarex and Organon Announce Biotherapeutics Development Agreement
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 May 2007
Cortex and the University of Alberta Complete Patent License Agreement
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 4 May 2007
Schering-Plough Receives Request for Additional Information From Federal Trade Commission in Connection With Planned Organon Biosciences N.V. Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2007
Lexicon Genetics Changes Name to Lexicon Pharmaceuticals as Drug Development Pipeline Progresses
Biopharmaceuticals
 HSMN NewsFeed - 10 Apr 2007
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 21 Mar 2007
Lexicon Genetics Appoints Tamar Howson Executive Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2007
Schering-Plough to Acquire Organon BioSciences
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Mar 2007
Cortex Pharmaceuticals Appoints Les Street, Ph.D., Head of Medicinal Chemistry and Steven A. Johnson, Ph.D., VP of Pre-Clinical Development Becomes an Officer of Cortex
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2007
Lexicon Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2007
Ligand Pharmaceuticals Completes Sale of AVINZA to King Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Dec 2006
Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of CIMA LABS
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Nov 2006
Organon and Pfizer Discontinue Their Collaboration on Asenapine
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2006
Pharmacopeia Announces the Appointment of Vice President, Clinical and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2006
Kosan Appoints Robert De Jager as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 18 Jul 2006
FDA Approves IMPLANON(TM) (etonogestrel implant) 68mg, the First and Only Single-Rod Implantable Contraceptive
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 28 Jun 2006
Nereus Pharmaceuticals Appoints Dr. Charles White as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2006
Pharmacopeia Announces Management Changes
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 97

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 97 additional stories matching:
Organon
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.